title: Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.
abstract: BACKGROUND
  In order to influence every day clinical practice professional organisations issue management guidelines. Cross-sectional surveys are used to evaluate the implementation of such guidelines. The present survey investigated screening for glucose perturbations in people with coronary artery disease and compared patients with known and newly detected type 2 diabetes with those without diabetes in terms of their life-style and pharmacological risk factor management in relation to contemporary European guidelines.
  
  
  METHODS
  A total of 6187 patients (18-80 years) with coronary artery disease and known glycaemic status based on a self reported history of diabetes (previously known diabetes) or the results of an oral glucose tolerance test and HbA1c (no diabetes or newly diagnosed diabetes) were investigated in EUROASPIRE IV including patients in 24 European countries 2012-2013. The patients were interviewed and investigated in order to enable a comparison between their actual risk factor control with that recommended in current European management guidelines and the outcome in previously conducted surveys.
  
  
  RESULTS
  A total of 2846 (46%) patients had no diabetes, 1158 (19%) newly diagnosed diabetes and 2183 (35%) previously known diabetes. The combined use of all four cardioprotective drugs in these groups was 53, 55 and 60%, respectively. A blood pressure target of <140/90 mmHg was achieved in 68, 61, 54% and a LDL-cholesterol target of <1.8 mmol/L in 16, 18 and 28%. Patients with newly diagnosed and previously known diabetes reached an HbA1c <7.0% (53 mmol/mol) in 95 and 53% and 11% of those with previously known diabetes had an HbA1c >9.0% (>75 mmol/mol). Of the patients with diabetes 69% reported on low physical activity. The proportion of patients participating in cardiac rehabilitation programmes was low (≈40 %) and only 27% of those with diabetes had attended diabetes schools. Compared with data from previous surveys the use of cardioprotective drugs had increased and more patients were achieving the risk factor treatment targets.
  
  
  CONCLUSIONS
  Despite advances in patient management there is further potential to improve both the detection and management of patients with diabetes and coronary artery disease.
authors.affiliation: Cardiology Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Solna, 171 76, Stockholm, Sweden. vivecagyberg@gmail.com.|Centre for Family Medicine, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden. vivecagyberg@gmail.com.
authors.forename: Viveca
authors.initials: V
authors.lastname: Gyberg
authors.affiliation: European Society of Cardiology, Les Templiers, 2035 route des Colles, CS 80179 BIOT, 06903, Sophia Antipolis Cedex, France. Dirk.DeBacquer@UGent.be.|Department of Public Health, Ghent University, Ghent, Belgium. Dirk.DeBacquer@UGent.be.
authors.forename: Dirk
authors.initials: D
authors.lastname: De Bacquer
authors.affiliation: European Society of Cardiology, Les Templiers, 2035 route des Colles, CS 80179 BIOT, 06903, Sophia Antipolis Cedex, France. guy.debacker@ugent.be.|Department of Public Health, Ghent University, Ghent, Belgium. guy.debacker@ugent.be.
authors.forename: Guy
authors.initials: G
authors.lastname: De Backer
authors.affiliation: European Society of Cardiology, Les Templiers, 2035 route des Colles, CS 80179 BIOT, 06903, Sophia Antipolis Cedex, France. c.jennings@imperial.ac.uk.|Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, London, UK. c.jennings@imperial.ac.uk.
authors.forename: Catriona
authors.initials: C
authors.lastname: Jennings
authors.affiliation: European Society of Cardiology, Les Templiers, 2035 route des Colles, CS 80179 BIOT, 06903, Sophia Antipolis Cedex, France. k.kotseva@imperial.ac.uk.|Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, London, UK. k.kotseva@imperial.ac.uk.
authors.forename: Kornelia
authors.initials: K
authors.lastname: Kotseva
authors.affiliation: Cardiology Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Solna, 171 76, Stockholm, Sweden. linda.mellbin@ki.se.|European Society of Cardiology, Les Templiers, 2035 route des Colles, CS 80179 BIOT, 06903, Sophia Antipolis Cedex, France. linda.mellbin@ki.se.
authors.forename: Linda
authors.initials: L
authors.lastname: Mellbin
authors.affiliation: Forschergruppe Diabetes e.V. at the Helmholtz Center, Munich, Germany. Oliver.Schnell@lrz.uni-muenchen.de.
authors.forename: Oliver
authors.initials: O
authors.lastname: Schnell
authors.affiliation: European Society of Cardiology, Les Templiers, 2035 route des Colles, CS 80179 BIOT, 06903, Sophia Antipolis Cedex, France. jaakko.tuomilehto@thl.fi.|Centre for Vascular Prevention, Danube-University Krems, Krems, Austria. jaakko.tuomilehto@thl.fi.|Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland. jaakko.tuomilehto@thl.fi.|Instituto de Investigacion Sanitaria del Hospital Universario LaPaz (IdiPAZ), Madrid, Spain. jaakko.tuomilehto@thl.fi.|Diabetes Research Group, King Abdulaziz University, Jeddah, Saudi Arabia. jaakko.tuomilehto@thl.fi.
authors.forename: Jaakko
authors.initials: J
authors.lastname: Tuomilehto
authors.affiliation: European Society of Cardiology, Les Templiers, 2035 route des Colles, CS 80179 BIOT, 06903, Sophia Antipolis Cedex, France. d.wood@imperial.ac.uk.|Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, London, UK. d.wood@imperial.ac.uk.
authors.forename: David
authors.initials: D
authors.lastname: Wood
authors.affiliation: Cardiology Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Solna, 171 76, Stockholm, Sweden. Lars.Ryden@ki.se.|European Society of Cardiology, Les Templiers, 2035 route des Colles, CS 80179 BIOT, 06903, Sophia Antipolis Cedex, France. Lars.Ryden@ki.se.
authors.forename: Lars
authors.initials: L
authors.lastname: Rydén
authors.affiliation: Institut Pasteur de Lille, Inserm U744, Université Lille Nord de France, 1 rue du Professeur Calmette B.P. 245, 59019, Lille, France. Philippe.amouyel@pasteur-lille.Fr.
authors.forename: Philippe
authors.initials: P
authors.lastname: Amouyel
authors.affiliation: European Society of Cardiology, Les Templiers, 2035 route des Colles, CS 80179 BIOT, 06903, Sophia Antipolis Cedex, France. jan.bruthans@seznam.cz.|Center for Cardiovascular Prevention, 1st School of Medicine, Charles University and Thomayer Hospital, Vídeňská 800, 140 59, Prague, Czech Republic. jan.bruthans@seznam.cz.
authors.forename: Jan
authors.initials: J
authors.lastname: Bruthans
authors.affiliation: Cardiac Rehabilitation Unit, Cardiology Department, Hospital Universitario La Paz, Madrid, Spain. almudenacastroconde@yahoo.es.
authors.forename: Almudena Castro
authors.initials: AC
authors.lastname: Conde
authors.affiliation: European Society of Cardiology, Les Templiers, 2035 route des Colles, CS 80179 BIOT, 06903, Sophia Antipolis Cedex, France. renata.cifkova@ftn.cz.|Center for Cardiovascular Prevention, 1st School of Medicine, Charles University and Thomayer Hospital, Vídeňská 800, 140 59, Prague, Czech Republic. renata.cifkova@ftn.cz.
authors.forename: Renata
authors.initials: R
authors.lastname: Cifkova
authors.affiliation: European Society of Cardiology, Les Templiers, 2035 route des Colles, CS 80179 BIOT, 06903, Sophia Antipolis Cedex, France. j.deckers@erasmusmc.nl.|Thoraxcenter's Department of Cardiology, Dr Molewaterplein 50, 3000 DR, Rotterdam, The Netherlands. j.deckers@erasmusmc.nl.
authors.forename: Jaap W
authors.initials: JW
authors.lastname: Deckers
authors.affiliation: European Society of Cardiology, Les Templiers, 2035 route des Colles, CS 80179 BIOT, 06903, Sophia Antipolis Cedex, France. johan.desutter@ugent.be.|Department of Internal Medicine, University of Ghent, De Pintelaan 185, 9000, Ghent, Belgium. johan.desutter@ugent.be.
authors.forename: Johan
authors.initials: J
authors.lastname: De Sutter
authors.affiliation: European Society of Cardiology, Les Templiers, 2035 route des Colles, CS 80179 BIOT, 06903, Sophia Antipolis Cedex, France. mdilic@bih.net.ba.|Clinical Center University of Sarajevo, Bolnička 25, 71000, Sarajevo, Bosnia and Herzegovina. mdilic@bih.net.ba.
authors.forename: Mirza
authors.initials: M
authors.lastname: Dilic
authors.affiliation: Department of Cardiology of Shupyk's Medical Academy of Postgraduate Education, 9 Dorohozhyts'ka str, Kiev, 04112, Ukraine. marinadolzhenko@mail.ru.
authors.forename: Maryna
authors.initials: M
authors.lastname: Dolzhenko
authors.affiliation: European Society of Cardiology, Les Templiers, 2035 route des Colles, CS 80179 BIOT, 06903, Sophia Antipolis Cedex, France. a.a.erglis@stradini.lv.|University of Latvia, Pauls Stradins Clinical University Hospital, Pilsonu Street 13, Riga, 1002, Latvia. a.a.erglis@stradini.lv.
authors.forename: Andrejs
authors.initials: A
authors.lastname: Erglis
authors.affiliation: European Society of Cardiology, Les Templiers, 2035 route des Colles, CS 80179 BIOT, 06903, Sophia Antipolis Cedex, France. zlatko.fras@telemach.net.|Preventive Cardiology Unit, Division of Internal Medicine, University Medical Centre Ljubljana, Zaloška 7, 1525, Ljubljana, Slovenia. zlatko.fras@telemach.net.|Medical Faculty, University of Ljubljana, Vrazov trg 2, 1000, Ljubljana, Slovenia. zlatko.fras@telemach.net.
authors.forename: Zlatko
authors.initials: Z
authors.lastname: Fras
authors.affiliation: European Society of Cardiology, Les Templiers, 2035 route des Colles, CS 80179 BIOT, 06903, Sophia Antipolis Cedex, France. dgaita@cardiologie.ro.|Institutul de Boli Cardiovasculare, Universitatea de Medicina si Farmacie "Victor Babes", Timisoara, Romania. dgaita@cardiologie.ro.
authors.forename: Dan
authors.initials: D
authors.lastname: Gaita
authors.affiliation: Department of Cardiology, National Heart Hospital, 65, Konyovitsa, 1309, Sofia, Bulgaria. ngotcheva@abv.bg.
authors.forename: Nina
authors.initials: N
authors.lastname: Gotcheva
authors.affiliation: European Society of Cardiology, Les Templiers, 2035 route des Colles, CS 80179 BIOT, 06903, Sophia Antipolis Cedex, France. igoudev@cc.uoi.gr.|Cardiology Department of Medical School, University of Ioannina, Ioannina, Greece. igoudev@cc.uoi.gr.
authors.forename: John
authors.initials: J
authors.lastname: Goudevenos
authors.affiliation: Institute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany. E_Heuschma_P@klinik.uni-wuerzburg.de.|Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany. E_Heuschma_P@klinik.uni-wuerzburg.de.|Clinical Trial Center Würzburg, University Hospital Würzburg, Josef-Schneider-Str. 2, 97080, Würzburg, Germany. E_Heuschma_P@klinik.uni-wuerzburg.de.
authors.forename: Peter
authors.initials: P
authors.lastname: Heuschmann
authors.affiliation: European Society of Cardiology, Les Templiers, 2035 route des Colles, CS 80179 BIOT, 06903, Sophia Antipolis Cedex, France. alius@cardio.it.|Clinic of Cardiovascular Diseases of Vilnius University, Santariskiu 2, 08661, Vilnius, Lithuania. alius@cardio.it.|Heart and Vascular Medicine of Vilnius University Hospital Santariskiu Clinics, Santariskiu 2, 08661, Vilnius, Lithuania. alius@cardio.it.
authors.forename: Aleksandras
authors.initials: A
authors.lastname: Laucevicius
authors.affiliation: Kuopio University Hospital, Rakennus 5/6. Kerros, Puijonlaaksontie 2, 70210, Kuopio, Finland. seppo.lehto@varkaus.fi.
authors.forename: Seppo
authors.initials: S
authors.lastname: Lehto
authors.affiliation: European Society of Cardiology, Les Templiers, 2035 route des Colles, CS 80179 BIOT, 06903, Sophia Antipolis Cedex, France. draganl1@sbb.rs.|Clinic for Internal Medicine Intermedica, Jovana Ristica 20/2, 18000, Nis, Serbia. draganl1@sbb.rs.
authors.forename: Dragan
authors.initials: D
authors.lastname: Lovic
authors.affiliation: European Society of Cardiology, Les Templiers, 2035 route des Colles, CS 80179 BIOT, 06903, Sophia Antipolis Cedex, France. d.milicic@mail.inet.hr.|University of Zagreb School of Medicine and University Hospital Centre Zagreb, Kispaticeva 12, HR-10000, Zagreb, Croatia. d.milicic@mail.inet.hr.
authors.forename: Davor
authors.initials: D
authors.lastname: Miličić
authors.affiliation: The Adelaide and Meath Hospital, Tallaght, Dublin 24, Ireland. David.Moore@amnch.ie.
authors.forename: David
authors.initials: D
authors.lastname: Moore
authors.affiliation: European Society of Cardiology, Les Templiers, 2035 route des Colles, CS 80179 BIOT, 06903, Sophia Antipolis Cedex, France. evnicor@cytanet.com.cy.|University of Nicosia Medical School, Nicosia General Hospital, 2029 Strovolos, Nicosia, Cyprus. evnicor@cytanet.com.cy.
authors.forename: Evagoras
authors.initials: E
authors.lastname: Nicolaides
authors.affiliation: National Research Center for Preventive Medicine of the Ministry of Healthcare of the Russian Federation, 10 Petroverigsky per, 101990, Moscow, Russia. oganov@gnicpm.ru.
authors.forename: Raphael
authors.initials: R
authors.lastname: Oganov
authors.affiliation: Department of Epidemiology and Population Studies, Faculty of Health Sciences, Jafiellonian University Medical College, Grzegórzecka 20, 31-531, Cracow, Poland. andrzej.pajak@uj.edu.pl.
authors.forename: Andrzej
authors.initials: A
authors.lastname: Pająk
authors.affiliation: European Society of Cardiology, Les Templiers, 2035 route des Colles, CS 80179 BIOT, 06903, Sophia Antipolis Cedex, France. NPogosova@gnicpm.ru.|Federal Health Centre and Department of Chronic Noncommunicable Diseases Prevention, National Research Centre for Preventive Medicine, 10 Petroverigsky per, 101953, Moscow, Russia. NPogosova@gnicpm.ru.
authors.forename: Nana
authors.initials: N
authors.lastname: Pogosova
authors.affiliation: European Society of Cardiology, Les Templiers, 2035 route des Colles, CS 80179 BIOT, 06903, Sophia Antipolis Cedex, France. zreiner@kbc-zagreb.hr.|University Hospital Centre Zagreb, School of Medicine, University of Zagreb, Kišpatićeva 12, 10000, Zagreb, Croatia. zreiner@kbc-zagreb.hr.
authors.forename: Zeljko
authors.initials: Z
authors.lastname: Reiner
authors.affiliation: Department of Heart failure and Valve Disease, Skåne University Hospital, Lund, Sweden. Martin.Stagmo@skane.se.
authors.forename: Martin
authors.initials: M
authors.lastname: Stagmo
authors.affiliation: Comprehensive Heart Failure Centre and Department of Medicine I, University of Würzburg, Straubmühlweg 2a, 97078, Würzburg, Germany. Stoerk_S@medizin.uni-wuerzburg.de.
authors.forename: Stefan
authors.initials: S
authors.lastname: Störk
authors.affiliation: European Society of Cardiology, Les Templiers, 2035 route des Colles, CS 80179 BIOT, 06903, Sophia Antipolis Cedex, France. lalet@hacettepe.edu.tr.|Hacettepe University, 06690, Ankara, Turkey. lalet@hacettepe.edu.tr.
authors.forename: Lale
authors.initials: L
authors.lastname: Tokgözoğlu
authors.affiliation: Centre for Medical Research, School of Medicine, University of Banja Luka, Vuka Karadzica 6, 78000, Banja Luka, Republic of Srpska, Bosnia and Herzegovina. dule@blic.net.
authors.forename: Dusko
authors.initials: D
authors.lastname: Vulic
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure; D002316:Cardiotonic Agents / Q000627:therapeutic use; D008078:Cholesterol, LDL / Q000378:metabolism; D003324:Coronary Artery Disease / Q000150:complications / Q000188:drug therapy*; D003430:Cross-Sectional Studies; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D050171:Dyslipidemias / Q000150:complications / Q000188:drug therapy / Q000378:metabolism; D005060:Europe; D005260:Female; D019983:Guideline Adherence; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D012042:Registries; D012307:Risk Factors; D055502:Secondary Prevention
chemical_list: D000319:Adrenergic beta-Antagonists; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002316:Cardiotonic Agents; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007004:Hypoglycemic Agents; D010975:Platelet Aggregation Inhibitors